Authors: Ross, AM Molhoek, P Lundergan, C Knudtson, M Draoui, Y Regalado, L Le Louer, V Bigonzi, F Schwartz, W de Jong, E Coyne, K

Citation: Am. Ross et al., Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin - Second trial of heparin and aspirin reperfusion therapy (HART II), CIRCULATION, 104(6), 2001, pp. 648-652

Authors: O'Neill, WW Serruys, P Knudtson, M van Es, GA Timmis, GC van der Zwaan, C Kleiman, J Gong, JJ Roecker, EB Dreiling, R Alexander, J Anders, R

Citation: Ww. O'Neill et al., Long-term treatment with a platelet glycoprotein-receptor antagonist afterpercutaneous coronary revascularization., N ENG J MED, 342(18), 2000, pp. 1316-1324

Authors: O'Neill, WW Serruys, P Knudtson, M Van Es, GA Timmis, GC van der Zwaan, C Kleiman, J Barker, K Dreiling, R Hubbard, R Alexander, J Anders, R

Citation: Ww. O'Neill et al., Design and objectives of the Evaluation of Oral Xemilofiban in ControllingThrombotic Events (EXCITE) study, J INTERV CA, 12(2), 1999, pp. 109-115

Authors: Manyari, DE Humen, DP Knudtson, M

Citation: De. Manyari et al., Nuclear cardiology after angioplasty and stent placement: Beyond sensitivity and specificity, J AM COL C, 34(4), 1999, pp. 1042-1044